File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Alectinib (ALC) vs crizotinib (CRZ) in treatment-naïve ALK+ non-small-cell lung cancer (NSCLC): Asian vs non-Asian subgroup analysis of the ALEX study

TitleAlectinib (ALC) vs crizotinib (CRZ) in treatment-naïve ALK+ non-small-cell lung cancer (NSCLC): Asian vs non-Asian subgroup analysis of the ALEX study
Authors
Issue Date2017
PublisherOxford University Press. The Journal's web site is located at http://annonc.oxfordjournals.org/
Citation
European Society for Medical Oncology (ESMO) Asia Congress, Singapore, 17–19 November 2017. In Annals of Oncology, 2017, v. 28 n. Suppl. 10, p. x191, abstract no. no. 410O PR How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/275861
ISSN
2017 Impact Factor: 13.93
2015 SCImago Journal Rankings: 4.362

 

DC FieldValueLanguage
dc.contributor.authorMok, T-
dc.contributor.authorPeter, S-
dc.contributor.authorCamidge, DR-
dc.contributor.authorOu, SH-
dc.contributor.authorAhn, JS-
dc.contributor.authorTan, EH-
dc.contributor.authorLi, Z-
dc.contributor.authorLee, JS-
dc.contributor.authorCho, BC-
dc.contributor.authorGeater, S-
dc.contributor.authorSriuranpong, V-
dc.contributor.authorHo, JCM-
dc.contributor.authorChan, SH-
dc.contributor.authorZeiter, A-
dc.contributor.authorBalas, B-
dc.contributor.authorNueesch, E-
dc.contributor.authorMitry, E-
dc.contributor.authorMorcos, PN-
dc.contributor.authorKim, DW-
dc.date.accessioned2019-09-10T02:51:08Z-
dc.date.available2019-09-10T02:51:08Z-
dc.date.issued2017-
dc.identifier.citationEuropean Society for Medical Oncology (ESMO) Asia Congress, Singapore, 17–19 November 2017. In Annals of Oncology, 2017, v. 28 n. Suppl. 10, p. x191, abstract no. no. 410O PR-
dc.identifier.issn0923-7534-
dc.identifier.urihttp://hdl.handle.net/10722/275861-
dc.languageeng-
dc.publisherOxford University Press. The Journal's web site is located at http://annonc.oxfordjournals.org/-
dc.relation.ispartofEuropean Society for Medical Oncology (ESMO) Asia Congress, 2017-
dc.relation.ispartofAnnals of Oncology-
dc.titleAlectinib (ALC) vs crizotinib (CRZ) in treatment-naïve ALK+ non-small-cell lung cancer (NSCLC): Asian vs non-Asian subgroup analysis of the ALEX study-
dc.typeConference_Paper-
dc.identifier.emailHo, JCM: jhocm@hku.hk-
dc.identifier.authorityHo, JCM=rp00258-
dc.description.naturelink_to_OA_fulltext-
dc.identifier.doi10.1093/annonc/mdx729.009-
dc.identifier.hkuros304726-
dc.identifier.volume28-
dc.identifier.issueSuppl. 10-
dc.identifier.spagex191-
dc.identifier.epagex191-
dc.publisher.placeUnited Kingdom-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats